发明名称 FUSED BENZENE DERIVATIVE AND USE
摘要 A compound represented by the general formula (I) [wherein ring A represents an optionally substituted 5- to 8-membered ring; ring B represents a further optionally substituted 4- to 10-membered ring; ring C represents a further optionally substituted benzene ring; X1 represents carbon; X2 represents carbon, oxygen, etc.; W represents nitrogen, etc.; Y11 represents a group represented by the formula CR2R3' (wherein R2 represents hydrogen, cyano, nitro, etc. and R3' represents hydrogen, cyano, nitro, etc.); Y21 represents a group represented by the formula CR4R5' (wherein R4 represents hydrogen, cyano, nitro, etc. and R5' represents hydrogen, cyano, nitro, etc.), etc.; R 1 represents an electron-attracting group; and the symbol ... represents a single bond or double bond]. The compound is useful as an androgen receptor modulator. Also provided is a salt of the compound.
申请公布号 CA2495383(A1) 申请公布日期 2004.02.26
申请号 CA20032495383 申请日期 2003.08.11
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 KUSAKA, MASAMI;HARA, TAKAHITO;SHIRAISHI, MITSURU;KANZAKI, NAOYUKI;YAMAMOTO, SATOSHI;MIYAWAKI, TOSHIO
分类号 A61P5/26;A61P13/08;A61P15/00;A61P15/10;A61P15/12;A61P19/10;A61P35/00;A61P43/00;C07C35/52;C07C217/04;C07C255/52;C07C255/53;C07C255/54;C07C255/56;C07D207/06;C07D207/08;C07D207/10;C07D207/12;C07D207/14;C07D207/16;C07D207/22;C07D207/24;C07D209/46;C07D211/22;C07D211/28;C07D211/34;C07D211/42;C07D211/46;C07D211/60;C07D211/62;C07D211/74;C07D231/08;C07D261/04;C07D265/02;C07D267/10;C07D295/073;C07D295/112;C07D295/155;C07D303/46;C07D307/79;C07D333/54;C07D405/04;C07D409/04;C07D491/10;C07D491/113;(IPC1-7):C07C35/52;C07D217/04;C07D231/04;A61K31/045;C07D231/06;C07D295/06;C07D211/14;C07D295/14;A61K31/277;A61K31/336;A61K31/402;A61K31/403;A61K31/42;A61K31/438;C07D209/44;A61K31/445;A61K31/45;A61K31/451;A61K31/452;A61K31/453;A61K31/472;A61K31/495;A61K31/535;A61K31/537;A61K31/54;A61K31/55;A61K31/553;C07D307/81 主分类号 A61P5/26
代理机构 代理人
主权项
地址